Hem › Sickelcellssjukdom › Alabama › Birmingham
Kliniska studier för Sickelcellssjukdom i Birmingham, AL
14 studier för Sickelcellssjukdom söker deltagare vid platser i och runt Birmingham (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
RekryterarFas 3
- University Of Alabama, Birmingham
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
RekryterarFas 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
RekryterarFas 3
- Uni of Alabama at Birmingham, Birmingham
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
RekryterarFas 1/2Friska volontärer välkomna
- University of Alabama Birmingham, Birmingham
SCD Stem Cell Mobilization and Apheresis Using Motixafortide
RekryterarFas 1
- University of Alabama at Birmingham, Birmingham
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
RekryterarFas 1/2Friska volontärer välkomna
- University of Alabama at Birmingham, Birmingham
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
RekryterarFas 3
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
Early Life Exposures Among Children With Sickle Cell Disease
Rekryterar
- University of Alabama at Birmingham, Birmingham
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
RekryterarFas 4
- University Of Alabama, Birmingham
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
RekryterarObservationsstudie
- Children's of Alabama (MRD-HCT), Birmingham
- Children's of Alabama (NT-DMT), Birmingham
Cognitive Remediation Intervention to Prepare for Transition of Care
RekryterarFas 2
- University of Alabama at Birmingham, Birmingham
A Long-term Follow-up Study in Patients Who Received BEAM-101
RekryterarObservationsstudie
- University of Alabama at Birmingham, Birmingham
HPC Offered for PRESERVE Expansion
RekryterarObservationsstudie
- University of Alabama, Birmingham, Birmingham
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
RekryterarObservationsstudie
- University of Alabama, Birmingham (UAB), Birmingham
Sickelcellssjukdom-studier i andra städer
- Atlanta, GA22 studier
- Washington, DC20 studier
- Memphis, TN18 studier
- Chicago, IL18 studier
- Philadelphia, PA15 studier
- New York City, NY13 studier
- St. Louis, MO12 studier
- Durham, NC10 studier
- Cincinnati, OH10 studier
- Boston, MA10 studier
- Houston, TX10 studier
- Pittsburgh, PA9 studier
Andra studier i Birmingham
- Cancer (alla typer)30 studier
- Bröstcancer24 studier
- Övervikt23 studier
- Äggstockscancer23 studier
- Icke-småcellig lungcancer22 studier
- Akut myeloid leukemi21 studier
- Multipelt myelom18 studier
- KOL17 studier
- Hjärt-kärlsjukdom17 studier
- Övervikt16 studier
- Endometriecancer16 studier
- Typ 2-diabetes16 studier
Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.